Bryce joins Rain as CMO; plus Ichnos, Dementia Discovery Fund, Akoya and more

Richard Bryce joined precision oncology company Rain Therapeutics Inc. as EVP and CMO. Most recently, Bryce was chief medical and scientific officer at Puma Biotechnology Inc. (NASDAQ:PBYI).

Oncology and autoimmune company Ichnos Sciences Inc. hired Cyril Konto as CMO, a new position. Konto joins from Allogene Therapeutics Inc. (NASDAQ:ALLO), where he was VP of clinical development...